Health Condition 1: E08-E13- Diabetes mellitus
Conditions
Interventions
Intervention1: Metformin: Metformin(orally)
500mg/BD
(1000mg/day)
6 weeks
Intervention2: Metformin + Aerobic exercises: Metformin(orally)
500mg/BD
(1000mg/day)
6 weeks
Aerobic exercises
(30min/day) f
Sponsors
Muhammad Institute of Medical and Allied sciences Multan
Komal Ammar Bukhari
Eligibility
Inclusion criteria
Inclusion criteria: 1. 20-60 years 2. Patients with T2DM 3. Both genders
Exclusion criteria
Exclusion criteria: 1. Vascular neoplasia 2. Fibromyalgia 3. Radiculopathy 4. Neuropathy 5. Tumor 6. Joint fractures 7. Vestibular problems 8. Congenital disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Osteocalcin levels will be measured using serum concentration assays (ELISA). Insulin levels will be assessed through fasting insulin tests Interleukin-6 (IL-6) levels will be quantified via serum cytokine assays (ELISA). Blood Glucose levels (Random and fasting blood glucose level)will be monitored using fasting blood glucose tests Hemoglobin A1c (HbA1c) for long-term glycemic control. Body Mass Index (BMI) will be calculated using height and weight measurements. Diabetes self-management will be assessed using the Diabetes Self-Management Questionnaire (DSMQ) , while Quality of life will be evaluated using the Diabetes Quality of Life (DQoL) Timepoint: 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid profile ( LDH,HDL,Triglycerides) Blood pressure VO2 max Physical fitness will be evaluated using the 6-minute walk test Timepoint: 6 weeks | — |
Countries
Pakistan
Contacts
Public ContactDr. Maliha Khalid Khan
Muhammad Nawaz Sharif University of Agriculture Multan
Outcome results
None listed